LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death

N V Somia1, M J Schmitt, D E Vetter

  • 1The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.

Insights

Researchers identified a novel gene, LFG, that specifically inhibits the Fas receptor-mediated programmed cell death pathway. This discovery offers new insights into controlling apoptosis and has implications for neurological conditions due to high LFG expression in the hippocampus.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Neuroscience

Background:

  • Programmed cell death, or apoptosis, is a crucial biological process that must be tightly regulated.
  • Dysregulation of apoptosis can lead to various pathological conditions.
  • The Fas receptor is a key mediator of apoptosis, and its signaling pathway requires precise control.

Purpose of the Study:

  • To identify novel molecules that can inhibit the apoptotic signaling initiated by the Fas receptor.
  • To characterize the function and properties of newly discovered inhibitors of Fas-mediated apoptosis.

Main Methods:

  • A genetic screen was employed to isolate genes that confer resistance to Fas-induced cell death.
  • Expression analysis was performed to determine the tissue distribution of the identified gene.
  • Biochemical assays were used to investigate the interaction of the gene product with the Fas receptor and its downstream signaling components.

Main Results:

  • A novel gene, designated LFG, was isolated for its unique ability to protect cells from Fas-induced apoptosis.
  • LFG specifically inhibits Fas-mediated death signaling, but not the related tumor necrosis factor alpha (TNF-α) pathway.
  • LFG is expressed broadly, with particularly high levels detected in the hippocampus.
  • LFG directly binds to the Fas receptor without affecting Fas expression, antibody binding, or FADD recruitment.

Conclusions:

  • LFG is a novel inhibitor of Fas receptor-mediated apoptosis.
  • The specific inhibition of Fas signaling by LFG suggests a targeted therapeutic potential.
  • High expression of LFG in the hippocampus may indicate a role in neuronal protection or regulation of apoptosis in the central nervous system.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...